Based on the aggregated intelligence of 170,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, consumer products giant Colgate-Palmolive
With that in mind, let's take a closer look at Colgate's business and see what CAPS investors are saying about the stock right now.
|Headquarters (founded)||New York City (1806)|
|Market Cap||$39.1 billion|
|Trailing-12-Month Revenue||$15.67 billion|
CEO Ian Cook
CFO Stephen Patrick
|Return on Capital (average, past 3 years)||35.9%|
Church & Dwight
Procter & Gamble
Sources: Capital IQ (a division of Standard & Poor's) and Motley Fool CAPS.
On CAPS, 96% of the 1,224 members who have rated Colgate believe the stock will outperform the S&P 500 going forward. These bulls include All-Star vinney11, who is ranked in the top 15% of our community, and ipfmanager.
Colgate's focus on, and dominance of, the global oral care industry continues to support its four-star CAPS status. Thanks to the cost advantages gained from its whopping 45% share of the toothpaste market, Colgate's three-year average return on capital (35.9%) tops that of rivals Church & Dwight (11%), Clorox (21.3%), and Procter & Gamble (10.1%), as well as other personal products giants like Johnson & Johnson
Such strong [tailwinds] with currency, taxation, globalization, population increase and otherwise have a beta of 0.5. They have almost zero legislative risk, competition, or business risk. Besides being one of the easiest companies to run and maintain, they will out pace the S&P by the sheer fact that industries shift over time, but everyone needs their ever increasing product line. Hold period time frame: 5-10 generations.
What do you think about Colgate, or any other stock for that matter? If you want to retire rich, you need to put together the best portfolio you can. Owning exceptional stocks is a surefire way to secure your financial future, and on Motley Fool CAPS, thousands of investors are working every day to find them. CAPS is 100% free, so get started!
Fool contributor Brian Pacampara owns no position in any of the companies mentioned. Clorox, Procter & Gamble, and Johnson & Johnson are all Motley Fool Income Investor picks. The Fool has written covered calls on Procter & Gamble. Motley Fool Options has recommended a diagonal call position on Johnson & Johnson. The Fool owns shares of Procter & Gamble and Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days.
We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Fool's disclosure policy always gets a perfect score.